This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration. Need a new registration confirmation email? Click here
Analysts estimate these stocks, from sectors such as medical devices, dental supplies and retail, to have upside potential ranging from 16% to 33%. An average of 57% of analysts rate them as a buy.
We present the stocks in order of their earnings release date.
Medtronic(MDT - Get Report) manufactures and sells device-based medical therapies. Medtronic will announce second-quarter fiscal 2012 results on Nov. 22.
Net income for 2012 second quarter is estimated at $872 million, or 82 cents per share, compared to $887 million, or 52 cents per share, in the year-ago quarter, according to analysts polled by
Bloomberg. Sales are seen increasing 4% to $40.7 billion for the quarter.
Gross margin is expected to drop slightly to 75.34%, vs. 75.38% during the same quarter 2011, while the per-share dividend is estimated to increase by 7% to 24 cents. Return on assets and equity is seen declining 72 and 686 basis points to 11.15% and 15.52%, respectively.
Of 34 analysts covering the stock, 38% recommend a buy and 62% suggest a hold. Analysts polled by
Bloomberg expect the stock to gain almost 17.5% to $39.8 from current levels over the next 12 months.